首页> 外文期刊>British Journal of Cancer >A prognostic score in histological node negative breast cancer
【24h】

A prognostic score in histological node negative breast cancer

机译:组织学淋巴结阴性乳腺癌的预后评分

获取原文
获取外文期刊封面目录资料

摘要

Between October 1977 and December 1983, 379 consecutive patients have been treated for unilateral, non-metastatic breast cancer, either with conservative (n = 205) or radical surgery (n = 174), with axillary dissection in all the cases. None of them had histologically proved lymph node involvement. Oestrogen receptor (ER) and progesterone receptor (PR) levels were measured on each tumour. Levels greater than 5 fmol mg-1 cytosolic protein were considered as positive for both ER and PR. At 5 years, overall survival (OS) and disease-free survival (DFS) are respectively 88% and 78%. Unifactorial analysis using Kaplan and Meier estimates and the log rank test revealed that OS was significantly related to age (P less than 0.05), tumour size (P less than 0.001), histological grading (SBR) (P less than 0.01), ER (P less than 0.001) and PR (P less than 0.001). DFS was significantly related to the same factors. Menopausal status, number of breast tumour foci and previous familial history of breast cancer were not significant. Multifactorial analysis revealed that DFS was significantly related to age (bad prognosis (b.p.) less than or equal to 37 years old), tumour size and histological grading (b.p. SBR = 3), and that OS was significantly related to tumour size and PR (b.p. PR less than or equal to 5 fmol mg-1 protein). A prognostic score has been constructed for both DFS and OS. These scores divide our patients into three significantly different (P less than 0.0001) groups with good, intermediate and bad prognosis.
机译:在1977年10月至1983年12月之间,连续379例接受了单侧,非转移性乳腺癌的患者接受了保守性手术(n = 205)或根治性手术(n = 174),并进行了腋窝淋巴结清扫术。他们都没有组织学证明淋巴结受累。在每个肿瘤上测量雌激素受体(ER)和孕激素受体(PR)的水平。大于5 fmol mg-1胞质蛋白的水平被认为对ER和PR均为阳性。在5年时,总生存期(OS)和无病生存期(DFS)分别为88%和78%。使用Kaplan和Meier估计的单因子分析以及对数秩检验显示OS与年龄(P小于0.05),肿瘤大小(P小于0.001),组织学分级(SBR)(P小于0.01),ER( P小于0.001)和PR(P小于0.001)。 DFS与相同因素显着相关。更年期状态,乳腺肿瘤灶数量和既往的乳腺癌家族史均不显着。多因素分析显示,DFS与年龄(不良预后(bp)小于或等于37岁),肿瘤大小和组织学分级(bp SBR = 3)显着相关,而OS与肿瘤大小和PR显着相关( bp PR小于或等于5 fmol mg-1蛋白)。已为DFS和OS构建了预后评分。这些评分将我们的患者分为预后好,中,差的三个明显不同的组(P小于0.0001)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号